Genomic analysis distinguishes phases of early development of the mouse atrio-ventricular canal.

  title={Genomic analysis distinguishes phases of early development of the mouse atrio-ventricular canal.},
  author={Pavle Vrljicak and Alex C Y Chang and Olena Morozova and Elizabeth D. Wederell and Kyle Niessen and Marco A. Marra and Aly Karsan and Pamela A. Hoodless},
  journal={Physiological genomics},
  volume={40 3},
Valve formation during embryonic heart development involves a complex interplay of regional specification, cell transformations, and remodeling events. While many studies have addressed the role of specific genes during this process, a global understanding of the genetic basis for the regional specification and development of the heart valves is incomplete. We have undertaken genome-wide transcriptional profiling of the developing heart valves in the mouse. Four Serial Analysis of Gene… 

Figures and Tables from this paper

Twist1 Transcriptional Targets in the Developing Atrio-Ventricular Canal of the Mouse
The findings support a role for TWist1 in the differentiation of AVC mesenchyme post-EMT in the mouse, and suggest that TWIST1 can exert its function by direct DNA binding to activate valve specific gene expression.
A Notch‐dependent transcriptional hierarchy promotes mesenchymal transdifferentiation in the cardiac cushion
It is shown that at E11.5, AVC‐EC retain the ability to undergo Notch‐dependent EMT when explanted on collagen, and 4 of the upstream TFs are validated as Notch targets that are enriched in AVc‐EC, and show these novel signaling pathways downstream of Notch are potentially relevant to valve development.
Transforming growth factor Beta2 is required for valve remodeling during heart development
Although the function of transforming growth factor beta2 (TGFβ2) in epithelial mesenchymal transition (EMT) is well studied, its role in valve remodeling remains to be fully explored. Here, we used
Deletion of RBP-J in adult mice leads to the onset of aortic valve degenerative diseases
Results suggest that RBP-J-mediated Notch signaling in aortic valves may be critically involved in valve homeostasis and valve diseases as well, and will be helpful for the understanding of the molecular mechanisms of AVD in adults.
Genetic and functional genomics approaches targeting the Notch pathway in cardiac development and congenital heart disease.
Functional data that implicates Notch in cardiac morphogenetic processes and expression profiling studies that enlighten the regulatory networks behind them are reviewed and a recurring theme is that Notch cross-talks reiteratively with other key signalling pathways to coordinate cell and tissue interactions during cardiogenesis.
A human cell model of cardiac pathophysiological valvulogenesis
A human pluripotent stem cell-derived model fit to decode the early steps of human valvulogenesis and to recapitulate valve disease traits in a dish is developed and extended to patient specific iPS cells, revealing that dysregulation of the SHH pathway is likely to be at the origin of the disease thus providing a putative therapeutic target.
Transforming Growth Factor Beta3 is Required for Cardiovascular Development
In vitro studies using TGFβ3-deficient fibroblasts in 3-D collagen lattice formation assays indicated that TGF β3 was required for collagen matrix reorganization, and biochemical studies indicated the ‘paradoxically’ increased activation of canonical (SMAD-dependent) and noncanonical (MAP kinase- dependent) pathways.
Human pre-valvular endocardial cells derived from pluripotent stem cells recapitulate cardiac pathophysiological valvulogenesis
A human cell model of valvulogenesis that faithfully recapitulates valve disease in a dish is reported and patient derived HPVCs have features of mitral valve prolapse and identified SHH dysregulation.


Activation of Notch1 signaling in cardiogenic mesoderm induces abnormal heart morphogenesis in mouse
The present study indicates that the Notch1 signaling pathway plays a suppressive role both in AV myocardial differentiation and the maturation of the ventricular myocardium.
Programmed cell death in the developing heart: Regulation by BMP4 and FGF2
  • Z. Zhao, S. Rivkees
  • Biology, Medicine
    Developmental dynamics : an official publication of the American Association of Anatomists
  • 2000
It is found that programmed cell death occurred in the areas in the endocardial cushions and trabeculae where rates of cell proliferation were low and was regulated by the growth factors, BMP4 and FGF2, in vitro.
Molecular markers of cardiac endocardial cushion development
A diverse set of molecular markers encompassing all stages of cardiac valve development are assembled and active Wnt/β‐catenin signaling in developing endocardial cushions suggests pathways that have not been previously appreciated to participate in cardiac valve formation.
Shared gene expression profiles in developing heart valves and osteoblast progenitor cells.
Shared gene expression profiles of the developing valves and osteoblast bone precursor cells in normal valve development and homeostasis with potential functions in calcific valve disease are supported.
Cell biology of cardiac cushion development.
Expression patterns of Tgfβ1–3 associate with myocardialisation of the outflow tract and the development of the epicardium and the fibrous heart skeleton
The spatiotemporal cardiovascular expression of Tgfβ1–3 supports both specific and complementary functions during cardiovascular development that might explain functional redundancy between the T gfβ‐isoforms.
Temporal and distinct TGFbeta ligand requirements during mouse and avian endocardial cushion morphogenesis.
Both TGF beta2 and TGFbeta3 appear necessary for the full morphogenetic program of EMT in the chick, but only TGFBeta2 is expressed and obligatory for mammalian endocardial cushion cell transformation.
Hesr1 and Hesr2 regulate atrioventricular boundary formation in the developing heart through the repression of Tbx2
It is shown that the forced expression of Hesr1 or Hesr2 in the entire cardiac lineage of the mouse results in the reduction or loss of the atrioventricular (AV) canal and the expression levels of specific markers of the AV myocardium, Bmp2 and Tbx2, are either very weak or undetectable.